⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 42 seconds ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 24, 2026

Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg Filmtabletten 200 mg/245 mg (Filmtablette)

📷 Wikipedia: Emtricitabine/tenofovir · Source
Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg Filmtabletten 200 mg/245 mg (Filmtablette)
📷 Wikipedia: Emtricitabine/tenofovir · Source
A delay affects the supply of Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg film-coated tablets.
⚠️
Shortage ongoing
EMTRICITABIN is currently in short supply in AT.
📈 Timeline
18 days active so far
August 25, 2026 September 11, 2026

What is this? This is a pill that combines two medicines, emtricitabine and tenofovir, used to treat infections.

What's happening? The pills are not being delivered right now. They will be back in November.

Does this affect me? If you take this pill, you may have trouble getting it until then.

What should I do? Ask your pharmacist or doctor for help finding another supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
EMTRICITABIN TENOFOVIR DISOPROXIL
Agency-published detail

ATC: J05AR03 · Reason: Verzögerung bei der Auslieferung · Marketing authorisation holder: Mylan, 117 Allee Des Parcs -, 69800 St Priest, French Republic · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-19, resupply 2026-11-23]

First published
August 24, 2026
Last refreshed by us
18 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 weeks ago

Emtricitabin/Tenofovir disoproxil ratiopharm 200 mg/245 mg Filmtabletten 200/245 mg (Filmtablette)

Parallel export is banned for this medicine. Supply is delayed due to manufacturing issues. The affected packs are the 30-tablet box and blister pack.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg Filmtabletten 200 mg/245 mg (Filmtablette). A delay affects the supply of Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg film-coated tablets.
▸ When was this alert issued?
This alert was issued on August 24, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.